These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 26032762

  • 1. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
    Garabedian C, Rakza T, Thomas D, Wibaut B, Vaast P, Subtil D, Houfflin-Debarge V.
    Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
    [Abstract] [Full Text] [Related]

  • 2. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P, Lardennois C, Galène-Gromez S, Brossard V, Marpeau L, Verspyck E, Marret S, le Réseau de périnatalité de Haute-Normandie.
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [Abstract] [Full Text] [Related]

  • 3. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP, Zeestraten EC, Lopriore E, van Kamp IL, Kanhai HH, Walther FJ.
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [Abstract] [Full Text] [Related]

  • 4. Management of red blood cell alloimmunization in pregnancy.
    Ghesquière L, Garabedian C, Coulon C, Verpillat P, Rakza T, Wibaut B, Delsalle A, Subtil D, Vaast P, Debarge V.
    J Gynecol Obstet Hum Reprod; 2018 May; 47(5):197-204. PubMed ID: 29476829
    [Abstract] [Full Text] [Related]

  • 5. Intrauterine Blood Transfusion for Parvo B19-Induced Fetal Anemia: Neuroimaging Findings and Long-Term Neurological Outcomes.
    Berezowsky A, Hochberg A, Regev N, Weisz B, Lipitz S, Yinon Y.
    Fetal Diagn Ther; 2023 May; 50(3):206-214. PubMed ID: 37231949
    [Abstract] [Full Text] [Related]

  • 6. Intrauterine management of fetal parvovirus B19 infection.
    Schild RL, Bald R, Plath H, Eis-Hübinger AM, Enders G, Hansmann M.
    Ultrasound Obstet Gynecol; 1999 Mar; 13(3):161-6. PubMed ID: 10204205
    [Abstract] [Full Text] [Related]

  • 7. Early Intrauterine Transfusion in Fetuses with Severe Anemia Caused by Parvovirus B19 Infection.
    Hellmund A, Geipel A, Berg C, Bald R, Gembruch U.
    Fetal Diagn Ther; 2018 Mar; 43(2):129-137. PubMed ID: 28633140
    [Abstract] [Full Text] [Related]

  • 8. [Intrauterine blood transfusion: Status report of 4years of practice in France (2011-2014)].
    Girault A, Friszer S, Maisonneuve E, Guilbaud L, Cortey A, Jouannic JM.
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):119-124. PubMed ID: 28403966
    [Abstract] [Full Text] [Related]

  • 9. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.
    Inglis SR, Lysikiewicz A, Sonnenblick AL, Streltzoff JL, Bussel JB, Chervenak FA.
    Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection.
    Nagel HT, de Haan TR, Vandenbussche FP, Oepkes D, Walther FJ.
    Obstet Gynecol; 2007 Jan; 109(1):42-7. PubMed ID: 17197586
    [Abstract] [Full Text] [Related]

  • 11. Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization.
    Poissonnier MH, Picone O, Brossard Y, Lepercq J.
    Fetal Diagn Ther; 2003 Jan; 18(6):467-71. PubMed ID: 14564122
    [Abstract] [Full Text] [Related]

  • 12. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection.
    Delle Chiaie L, Buck G, Grab D, Terinde R.
    Ultrasound Obstet Gynecol; 2001 Sep; 18(3):232-6. PubMed ID: 11555452
    [Abstract] [Full Text] [Related]

  • 13. Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit.
    Simms RA, Liebling RE, Patel RR, Denbow ML, Abdel-Fattah SA, Soothill PW, Overton TG.
    Fetal Diagn Ther; 2009 Sep; 25(4):373-8. PubMed ID: 19786782
    [Abstract] [Full Text] [Related]

  • 14. [Maternal blood intrauterine transfusions in the therapy of red-cell alloimmunization performed in three difficult cases].
    Kucińska-Chahwan A, Massalska D, Bijok J, Rudzińska M, Kopeć I, Rzymkiewicz L, Jakiel G, Roszkowski T.
    Ginekol Pol; 2014 Sep; 85(9):703-7. PubMed ID: 25322544
    [Abstract] [Full Text] [Related]

  • 15. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH.
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [Abstract] [Full Text] [Related]

  • 16. Clinical presentation and outcome of 20 fetuses with parvovirus B19 infection complicated by severe anemia and/or fetal hydrops.
    Macé G, Sauvan M, Castaigne V, Moutard ML, Cortey A, Maisonneuve E, Garel C, Dhombres F, Boujenah J, Mailloux A, Carbonne B.
    Prenat Diagn; 2014 Nov; 34(11):1023-30. PubMed ID: 24851784
    [Abstract] [Full Text] [Related]

  • 17. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R, Ochoa-Flores M, Hernández-Herrera RJ, Flores-Pompa E.
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
    Kriplani A, Malhotra Singh B, Mandal K.
    Gynecol Obstet Invest; 2007 Jun; 63(3):176-80. PubMed ID: 17143009
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.